rs200737038
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_004820.5(CYP7B1):c.334C>T(p.Arg112Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000404 in 1,610,756 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_004820.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CYP7B1 | NM_004820.5 | c.334C>T | p.Arg112Ter | stop_gained | 3/6 | ENST00000310193.4 | |
CYP7B1 | NM_001324112.2 | c.334C>T | p.Arg112Ter | stop_gained | 3/7 | ||
CYP7B1 | XM_017014002.2 | c.400C>T | p.Arg134Ter | stop_gained | 4/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CYP7B1 | ENST00000310193.4 | c.334C>T | p.Arg112Ter | stop_gained | 3/6 | 1 | NM_004820.5 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.0000792 AC: 12AN: 151478Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000141 AC: 35AN: 248024Hom.: 0 AF XY: 0.000119 AC XY: 16AN XY: 134538
GnomAD4 exome AF: 0.0000363 AC: 53AN: 1459164Hom.: 0 Cov.: 32 AF XY: 0.0000317 AC XY: 23AN XY: 725962
GnomAD4 genome ? AF: 0.0000792 AC: 12AN: 151592Hom.: 0 Cov.: 32 AF XY: 0.0000675 AC XY: 5AN XY: 74026
ClinVar
Submissions by phenotype
Spastic paraplegia Pathogenic:1Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Paris Brain Institute, Inserm - ICM | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Jan 17, 2024 | This sequence change creates a premature translational stop signal (p.Arg112*) in the CYP7B1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CYP7B1 are known to be pathogenic (PMID: 9802883, 19363635, 19439420, 21541746, 21567895, 28039895). This variant is present in population databases (rs200737038, gnomAD 0.2%). This premature translational stop signal has been observed in individual(s) with hereditary spastic paraplegia (PMID: 19439420, 24117163, 24641183, 29980238). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 219912). For these reasons, this variant has been classified as Pathogenic. - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 04, 2012 | Please see table 3 in supplementary results of the main report. This variant has not been detected in conjunction with a pathogenic mutation to date. This amino acid position is highly conserved in available vertebrate species. - |
Hereditary spastic paraplegia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Sep 01, 2019 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 09, 2017 | - - |
Congenital bile acid synthesis defect 3 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 09, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at